Site operations

Site initiation visit checklist

By TrialNotice · Updated
Coordinator in navy scrubs unlocking the door to a prepared clinical trial exam room
Short answerA site initiation visit goes smoothly when regulatory documents are complete, the full study team attends, facilities and drug storage are ready, systems access works, and every delegated task is on the log with training documented. The item most sites skip is an enrollment plan: candidates identified and referral sources briefed before the visit, so the first patient can be screened right after activation.

Why does the initiation visit matter?

It is the last step before enrollment opens, and the stretch from initiation to first patient in is the most variable part of startup (Applied Clinical Trials). Startup already averages 31.4 weeks from site identification (Tufts CSDD); a smooth visit keeps the final weeks from slipping.

Documents

  • IRB approval letters and approved consent forms, current version.
  • Signed Form FDA 1572 or investigator agreement, CVs, licenses, and GCP certificates.
  • Delegation log with every task and person, signed by the PI. Vague or outdated logs are a common inspection finding (CASRAI).
  • Signed contract and budget, lab certifications, and normal ranges.

People

  • PI present for the key sessions, plus sub investigators, coordinators, pharmacy, and lab staff.
  • Protocol and system training documented for each person.

Facilities and product

  • Secure, temperature monitored storage for investigational product. Product accountability gaps are a recurring FDA finding (FDA).
  • Lab kits received, with shipping supplies and courier accounts set up.
  • Equipment the protocol requires, calibrated.

Systems

  • EDC, IRT, and portal logins tested for each user.
  • Source document templates built from the schedule of assessments.

The enrollment plan

  • Candidates identified from records, ready to contact.
  • Referring physicians briefed on the study and how to refer.
  • Screening slots reserved for the first two weeks.

This last section is what separates a site that activates from a site that enrolls. See how to reach first patient in faster.

Get your study in front of the right local physicians

TrialNotice builds a physician referral pipeline around one active study. We identify relevant local physicians within driving distance of your site, send study aligned direct mail, follow up by email and LinkedIn, track engagement with recipient level QR codes, and route warm responses into your site team's workflow.

Talk to TrialNotice

Sources

  1. Applied Clinical Trials, "New Benchmarks for Trial Initiation Activities" (Tufts CSDD)
  2. Tufts CSDD, first comprehensive clinical site initiation benchmark (2018), via GlobeNewswire
  3. CASRAI, "GCP Inspections: What FDA and EMA Review, How to Prepare, and How to Respond to a 483"
  4. FDA, Bioresearch Monitoring (BIMO) Fiscal Year 2023 Metrics

Keep reading

Three clinical research coordinators laughing over coffee at a table in a sunny staff break room
Site operations

Why research coordinators leave, and how sites keep them

Site turnover runs 35% to 61% a year, and 85% of departing staff go to sponsors and CROs. Here is why coordinators leave, what turnover costs a site, and what keeps them.

 Tired coordinator in navy scrubs rubbing her eyes at a desk with two monitors and a stack of binders
Site operations

Sponsor training burden: where coordinator hours really go

Sites average 17.5 hours per study per month on training, and 65% of mandatory training is considered redundant. Here is the data, the industry efforts to cut it, and what sites can do now.

 Coordinator moving a sticky note on a crowded study calendar board in a research office
Site operations

Why study startup takes so long, and where sites lose weeks

Study startup averages 31.4 weeks from site identification, and the contract and budget stages take the largest share. Here is where the time goes and which delays a site controls.